Cassiopea Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Cassiopea General Information

Description

Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It is focused on developing and commercializing differentiated medical dermatology products. The company's focus is on the topical treatment of acne; Androgenic Alopecia, (or AGA); and genital warts. Its portfolio comprises four unencumbered clinical candidates namely: Winlevi, for the treatment of acne; Breezula, for the topical treatment of AGA; CB-06-02, for the treatment of genital warts; and CB-06-01, for the treatment of acne.

Contact Information

Formerly Known As
Cosmo Dermatos
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Former Stock Listing
SKIN
Primary Office
  • 6265 Greenwich Drive
  • Suite 210
  • San Diego, CA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cassiopea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cassiopea‘s full profile, request access.

Request a free trial

Cassiopea Patents

Cassiopea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3108879-A1 High concentration formulation Inactive 25-Jun-2015 00000000 0
AU-2016284935-A1 High concentration formulation Active 22-Jun-2015 0000000000
US-20220193093-A1 High concentration formulation Pending 22-Jun-2015 0000000000
US-20200222429-A1 High concentration formulation Active 22-Jun-2015 0000000000
US-20190374553-A1 High concentration formulation Active 22-Jun-2015 A61K31/573
To view Cassiopea’s complete patent history, request access »

Cassiopea Executive Team (4)

Name Title Board Seat Contact Info
Diana Harbort Chief Executive Officer & Board Member
Pierpaolo Guzzo Chief Financial Officer & Board Member
You’re viewing 2 of 4 executive team members. Get the full list »

Cassiopea Board Members (2)

Name Representing Role Since
00000 0000000 Cassiopea Chief Executive Officer & Board Member 000 0000
000000000 00000 Cassiopea Chief Financial Officer & Board Member 000 0000
To view Cassiopea’s complete board members history, request access »

Cassiopea Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial